Man Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-620,699
| Closed | -$81.9M | – | 2194 |
|
|
2025
Q1 | $81.9M | Buy |
620,699
+572,102
| +1,177% | +$75.5M | 0.21% | 83 |
|
|
2024
Q4 | $4.06M | Buy |
48,597
+21,098
| +77% | +$1.76M | 0.01% | 963 |
|
|
2024
Q3 | $2.01M | Sell |
27,499
-33,502
| -55% | -$2.45M | 0.01% | 1180 |
|
|
2024
Q2 | $4.18M | Buy |
61,001
+54,871
| +895% | +$3.76M | 0.01% | 983 |
|
|
2024
Q1 | $424K | Buy |
6,130
+3,021
| +97% | +$209K | ﹤0.01% | 1714 |
|
|
2023
Q4 | $223K | Buy |
+3,109
| New | +$223K | ﹤0.01% | 1772 |
|
|
2023
Q3 | – | Sell |
-229,536
| Closed | -$14.5M | – | 1714 |
|
|
2023
Q2 | $14.5M | Buy |
+229,536
| New | +$14.5M | 0.04% | 491 |
|
|
2021
Q2 | – | Sell |
-10,179
| Closed | -$345K | – | 2035 |
|
|
2021
Q1 | $345K | Buy |
+10,179
| New | +$345K | ﹤0.01% | 1592 |
|
|
2020
Q2 | – | Sell |
-26,000
| Closed | -$400K | – | 1819 |
|
|
2020
Q1 | $400K | Buy |
+26,000
| New | +$400K | ﹤0.01% | 1320 |
|
|
2019
Q3 | – | Sell |
-196,803
| Closed | -$2.56M | – | 1930 |
|
|
2019
Q2 | $2.56M | Sell |
196,803
-46,200
| -19% | -$600K | 0.01% | 1217 |
|
|
2019
Q1 | $2.96M | Buy |
243,003
+43,200
| +22% | +$526K | 0.01% | 1167 |
|
|
2018
Q4 | $2.28M | Sell |
199,803
-102,545
| -34% | -$1.17M | 0.01% | 1150 |
|
|
2018
Q3 | $6.56M | Sell |
302,348
-26,700
| -8% | -$579K | 0.02% | 834 |
|
|
2018
Q2 | $5.81M | Buy |
329,048
+112,289
| +52% | +$1.98M | 0.02% | 853 |
|
|
2018
Q1 | $4.56M | Buy |
+216,759
| New | +$4.56M | 0.02% | 883 |
|